News about Global Pharma

Cosette Pharmaceuticals Acquires Mayne Pharma to Expand Globally

Cosette will utilize its market-leading commercial and operational capabilities, backed by its 350+ strong team and a leading portfolio of women’s health and dermatology products alongside Mayne Pharma’s complementary strength in these specialty areas.

Global Pharma | 21/02/2025 | By Aishwarya |  806

Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma

Hilberdink will play a pivotal role in fostering Boehringer's culture and driving meaningful impact for patients.

Global Pharma | 21/02/2025 | By Aishwarya |  340

Lantern Pharma Submits PCT Patent Application for Machine Learning Model for BBB Permeability Prediction

The technology has demonstrated to-date exceptional performance in predicting BBB permeability across a wide range of chemical compounds, processing up to 100,000 molecules per hour with industry-leading accuracy.

Global Pharma | 20/02/2025 | By Aishwarya |  268

Orchid Pharma's Alathur API Facility Successfully Completes USFDA Inspection

Orchid Pharma has successfully completed a surprise USFDA inspection at its Alathur API facility, securing its status as India’s only USFDA-approved site for Sterile Cephalosporins. The facility also secures EU GMP certificate renewal for Cephalosporin API manufacturing.

Global Pharma | 20/02/2025 | By Abha |  582

Acurx Pharmaceuticals Secures Japanese Patent for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals has secured a new patent from the Japanese Patent Office for its DNA Polymerase IIIC Inhibitors, expanding its global intellectual property portfolio in antimicrobial drug development.

Global Pharma | 20/02/2025 | By Abha |  297

Celonic Group Signs Multi-Year Manufacturing Service Deal with LINDIS Biotech

Catumaxomab is a first-in-class, trifunctional bispecific monoclonal antibody designed for the intraperitoneal treatment of malignant ascites in adults with epithelial cell adhesion molecule (EpCAM)-positive carcinomas who are not eligible for other systemic anticancer therapy.

Global Pharma | 20/02/2025 | By Aishwarya |  330

Perceive Pharma Secures USD 15 Million in Series A Financing Round

Perceive Pharma is also pleased to announce that Carol Gallagher, Pharm.D. has joined the company's Board of Directors as an independent director.

Global Pharma | 19/02/2025 | By Aishwarya |  607

Rznomics Liver Cancer Drug RZ-001 Secures Fast Track Designation from US FDA

Rznomics' anticancer drug RZ-001 has received Fast Track Designation from the US FDA for the treatment of liver cancer – Hepatocellular Carcinoma (HCC), marking its second designation after Glioblastoma (GBM), to accelerate its clinical development.

Global Pharma | 19/02/2025 | By Abha |  285

VIVOZON Pharmaceutical Secures MFDS Approval for UNAFRA Inj.

With this milestone, UNAFRA Inj. has become the 38th innovative drug in Korea. UNAFRA Inj., discovered by using the company's proprietary multi-target drug development platform, is the world's first non-opioid, non-NSAIDS analgesic.

Global Pharma | 18/02/2025 | By Aishwarya |  341

Aveva Drug Delivery Systems Introduces Generic Fentanyl TDS in US

The launch of Fentanyl TDS, a prescription 3-day transdermal patch for managing moderate to severe chronic pain (generic equivalent to Duragesic®), required the rapid sourcing and seamless integration of advanced manufacturing equipment's with existing systems to meet regulatory and operational standards.

Global Pharma | 18/02/2025 | By Aishwarya |  194